Radiation Emergency Assistance Center/Training
Site
The Radiation Emergency Assistance Center/Training Site (REAC/TS)
program has been a significant part of DOE's radiation protection
effort for over 30 years. This program provides state-of-the-art medical
assistance, dosimetric assistance, and training efforts responsive
to the Department's radiation accidents as its first priority; and,
secondarily as a service on a worldwide basis. Personnel experienced
in clinical radiation medicine are available on a 24-hour basis to
evaluate patients directly or in consultation with their physicians,
to provide clinical care management, and medical followup of survivors
of serious radiation accidents. About 60 calls per year request this
specialized assistance. REAC/TS personnel can treat workers or members
of the public exposed to radiation or radioactive materials with appropriate
conventional and developmental protocols. From REAC/TS research and
registry of more than 400 past accident histories and pertinent clinical
data from over 133,000 exposed individuals, it has been able to study
the course of radiation induced pathology to suggest improvements
for specialized treatment protocols. In this context, the group conducts
maintains a selected inventory of chelating agents under Investigational
New Drug Applications (INDA) as ameliorative options. Over 5,000 physicians,
nurses, and emergency personnel have received REAC/TS training in
the medical aspects of radiation accident preparedness and management.
REAC/TS unique expertise in radiation medicine is sought frequently
by program offices in DOE and in other Federal agencies.
Accomplishments:
- Provided timely medical consultation and services to requests
for assistance.
- Established and maintained a comprehensive radiation accident
register.
- Enlisted and re-supplied co-investigators with fresh DTPA for
the IND program.
- Provided DTPA treatments.
Goals:
- Provide state-of-the-art expertise in radiation medicine.
- Continue to maintain and improve the REAC/TS radiation accident
registries.
- Maintain DTPA (diethylenetriaminepentaacetic acid) INDs and
increase DTPA inventories.
- Establish distribution of Prussian Blue to co-investigator
physicians.
- Continue REAC/TS educational and instructional programs.
- Improve radiation treatment options through research and further
clinical study.
Program Manager: Joseph F. Weiss
Related Documents & Links
(Back to the top) |